Hoth Therapeutics Revenue and Competitors

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is a biopharmaceutical visionary dedicated to finding, investigating and developing early-stage therapeutics that will change the way diseases are managed and treated. Guided by the belief that treatment should not make you sicker than the disease, Hoth Therapeutics seeks out overlooked drugs that hold the promise to improve treatments and address significant unmet needs for patients. Hoth Therapeutics follows the science to find the ideal indications for each asset and partners with leading companies in the space to bring therapies to market. At Hoth Therapeutics, we understand how devastating it can be to live with a chronic illness, be diagnosed with a rare disease, or the only option is to take a medicine that causes unrelenting side effects. We believe that every patient deserves to get the therapies they need to address their disease and improve their quality of life.